Form 4: Vaxart CEO Steven Lo Acquires 100,000 Shares of Common Stock
SEC Form 4 Filing
Vaxart's CEO, Steven Lo, indirectly acquired 100,000 shares of common stock through The Lo Family Trust at a price of $0.49 per share on May 19, 2025.
Summary
- On May 19, 2025, Steven Lo, the President and CEO of Vaxart, Inc., acquired 100,000 shares of Vaxart's common stock.
- The shares were acquired indirectly through The Lo Family Trust, where Mr. Lo serves as a trustee and beneficiary.
- The purchase price was $0.49 per share.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally seen as a positive sign, indicating confidence in the company's future. However, without more context, it's difficult to gauge the full impact.
Positives
- The CEO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often watched by investors as a signal of management's confidence in the company's prospects. However, it's important to consider the size of the purchase relative to the executive's overall holdings and the company's market capitalization.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase positively.
- The purchase does not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of transaction: Steven Lo acquired 100,000 shares of Vaxart's common stock. |
Keywords
Vaxart, VXRT, Steven Lo, CEO, stock acquisition, Form 4, insider trading, Lo Family Trust, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.